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 16 
ABSTRACT 17 
Three quantification methodologies, namely calibration with internal standard (Cal-IS, non-weighted), 18 
weighted calibration with internal standard (wCal-IS) and isotope pattern deconvolution (IPD) have been 19 
used for the determination of testosterone in urine by LC-MS/MS. Uncertainty has been calculated and 20 
compared for the three methodologies through intra- and inter-laboratory reproducibility assays. IPD 21 
showed the best performance for the intra-laboratory reproducibility, with RSD and combined uncertainty 22 
values below 4% and 9% respectively. wCal-IS showed similar performance, while Cal-IS where not constant 23 
and clearly worse at the lowest concentration assayed (2 ng/mL) reaching RSD values up to 16%. The inter-24 
laboratory assay indicated similar results although wCal-IS RSD (20%) was higher than IPD (10%) and Cal-IS 25 
get worse with RSD higher than 40% for the lowest concentration level. Uncertainty budgets calculated for 26 
the three procedures revealed that intercept and slope were the most important factors contributing to 27 
uncertainty for Cal-IS. The main factors for wCal-IS and IPD were the volumes of sample and/or standard 28 
measured. 29 
 30 
INTRODUCTION 31 
The use of drugs to enhance performance in sports is a well-known and documented issue. Despite the 32 
continuous introduction of new compounds, endogenous androgenic anabolic steroids (EAAS) are among 33 
the most popular doping agents[1–3]. EAAS determination still represents an important challenge due to 34 
the complexity to differentiate exogenous administration of endogenous substances. The goal requires 35 
collaborative efforts as well as advanced methodologies[1–7]. Longitudinal fluctuations measurement for a 36 
given athlete is nowadays regarded as the most effective approach to suspect the EAAS misuse. In this way, 37 
the steroidal profile of the Athlete Biological Passport (ABP) represents a powerful tool to reveal doping 38 
with endogenous compounds[1,3,6]. 39 
For most drugs, urine is the matrix generally used since it involves a non-invasive sampling procedure, large 40 
volumes are easily obtained, shows wide time windows and concentrations are high enough[1,6,7]. 41 
However, sample preparation is mandatory to ensure matrix effect attenuation and good sensitivity and 42 
selectivity. Usual treatment techniques such as solid phase extraction (SPE), liquid-liquid extraction (LLE) 43 
and simple matrix dilution are normally used. Due to its simplicity, efficiency and low cost, LLE at basic pH is 44 
still widely used in EAAS determination in urine samples[5,6]. Concerning identification and quantification, 45 
LC-MS based techniques –equipped with Electrospray Ionization source (ESI)- tend to replace GC-MS(/MS) –46 
considered as the gold World Anti-doping Agency (WADA) standard for quantifications[8]- since the former 47 
shows suitable sensitivity and faster instrumental run time. Specially UHPLC-MS/MS with its demonstrated 48 
separation efficiency is considered the method of choice in doping analysis[1,5,6,9]. 49 
A relevant problem with the use of ESI source is the signal alteration due to matrix effect[10-12]. Matrix 50 
effect can affect drastically to sensitivity, precision and accuracy of the analytical results. The most robust 51 
approach to minimize matrix effect rely on the use of Stable Isotope Labeled-Internal Standard (SIL-52 
IS)[11,12]. Thus, matrix-effects associated to complex matrices can be properly overcome using a 53 
quantification methodology based on isotope dilution mass spectrometry (IDMS). Classical IDMS is based 54 
on the preparation of methodological calibration curves with the associated time consumption. An 55 
alternative method of quantification, based on the measurement of isotopic abundances in the spiked 56 
sample by multiple linear regression, can also be used. This method, known as isotope pattern 57 
deconvolution (IPD), do not requires the construction of any calibration graph and has been tested 58 
satisfactorily for rapid quantifications in different complex matrices[13-16]. IDMS together with IPD is a fast 59 
and reliable methodology, which provides one result per injection with high accuracy and free of matrix 60 
effect. 61 
In the field of doping analysis, improvements of reliability and robustness of analytical results is 62 
continuously and still required[1,2,5,6]. WADA highlights the need of good inter-laboratory precision, 63 
particularly relevant in ABP profiling[5]. Analytical results for ABP are obtained from different laboratories 64 
for the same athlete, thus, improving inter-laboratory precision seems of maximum concern to allow 65 
universal application of any developed methodology. In this way, the need of calculating and minimizing 66 
measurement uncertainty deserves to be treated thoroughly[2,17,18]. 67 
In the present work, a previously developed method has been applied to assess the uncertainty in the 68 
testosterone concentration determined in several synthetic urine samples. Testosterone concentration has 69 
been calculated using three different methodologies, weighted and non-weighted calibration with IS (wCal-70 
IS and Cal-IS, respectively) and IPD. In order to evaluate more in depth the associated uncertainty, an inter-71 
laboratory comparison among five laboratories has been performed. For all three methodologies, intra- and 72 
inter-laboratory measurements have been conducted, combined uncertainties (uc) and full uncertainty 73 
budgets have been obtained and compared. 74 
 75 
EXPERIMENTAL 76 
Reagents and materials 77 
Testosterone (T, purity 99%) was provided by Sigma-Aldrich Co. (Madrid, Spain) and 13C2-testosterone (13C2-78 
T, purity 98% and 13C2-enrichment 98%) by Cambridge Isotope Laboratories (Andover, MA, USA). 79 
Methanol (MeOH, HPLC quality) and methyl tert-butyl ether (MTBE, GC quality) were provided by Scharlau 80 
(Barcelona, Spain). For the sample hydrolysis, β-glucuronidase from E. coli K12 provided by Roche 81 
(Indianapolis, IN, USA) was employed. A 1 M phosphate buffer was prepared by dissolving the proper 82 
amount of (NH4)2HPO4 (Merck, Darmstadt, Germany) in Milli-Q water and adjusted to pH=7 with HCl 37% 83 
from Scharlau (Barcelona, Spain). Also, a NaHCO3/Na2CO3 (1:2, w/w) (Sigma-Aldrich Co., Madrid, Spain) 84 
solid buffer was prepared. Formic acid (LC additive quality) and a 500 mM solution of NH4HCOO (Scharlau, 85 
Barcelona, Spain) in methanol HPLC were used for the mobile phase preparation. 86 
A 250 µg/mL stock solution of T was prepared by dissolving 25 mg of solid standard, accurately weighed, in 87 
100 mL of methanol. The stock solution of 13C2-T was prepared by dissolving 10 mg of the purchased 88 
material in 50 mL of methanol. This provided a concentration by reverse isotope dilution against the 89 
natural compound of 237 µg/mL. 90 
Individual 10 µg/mL and 1 µg/mL working solutions of the natural and labelled compounds were prepared 91 
by dilution of the stock solutions with methanol. All of the standard solutions were stored in amber glass 92 
bottles in a freezer. 93 
The water purification system used was a Milli-Q gradient A10 from Millipore (Bedford, MA, USA). 94 
 95 
Instrumentation 96 
All participants in the inter-laboratory comparison have determined testosterone by LC-MS/MS. 97 
Additionally some laboratories have used other methodologies (see inter-laboratory comparison section). 98 
This section describes the instrumentation used at Research Institute for Pesticides and Water (IUPA) 99 
laboratory, where the intra-laboratory measurements and all calculations have been done. 100 
An Acquity UPLC system coupled to a TQD triple quadrupole mass spectrometer from Waters Corp. 101 
(Milford, MA, USA) was employed for sample analysis. Chromatographic separation was performed with an 102 
Acquity UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm), also from Waters Corp., at a 0.3 mL/min flow 103 
rate and an injection volume of 10 µL. The column oven was kept at 55ºC and the sample manager at 10ºC. 104 
Mobile phase A was purified water and mobile phase B was MeOH HPLC, both containing 0.01% of formic 105 
acid and 1 mM of NH4HCOO as modifiers. The gradient applied was: 45% B (0-1 min), linear increase to 106 
77.5% B in 6.5 min, 95% B (7.51-8 min), 45% B (8.5-11.5 min). Chromatograms of blank and a selected 107 
sample can be seen in Figure S.8 in supplementary material. 108 
 109 
Table 1. Chemical structure and experimental conditions of the LC-(ESI)-MS/MS for testosterone and 110 
labeled testosterone 111 
Compound Structure 
Rt 
(min) 
Precursor 
ion 
Cone voltage 
(V) 
SRM transitions 
T 
 
5.7 [M+H]+ 30 
289.2 > 96.9 (25) 
290.2 > 96.9 (25) 
289.2 > 108.9 (25) 
13C2-T 
 
5.7 [M+H]+ 30 
291.2 > 98.9 (25) 
292.2 > 98.9 (25) 
 112 
Electrospray ionization in the mass spectrometer was performed at 120 ºC and 350 ºC source and 113 
desolvation temperatures, 80 and 800 L/h cone gas and desolvation flow, respectively, and 3.5 kV capillary 114 
voltage, operating in positive ion mode. MS/MS experimental conditions for T and 13C2-T are listed in Table 115 
1. 116 
Nitrogen was employed as both drying and nebulizing gas, obtained from a nitrogen generator N2 LC-MS 117 
adapted for LC-MS analyzers (Claind, Teknokroma, Barcelona, Spain). Collision cell was operated under a 118 
pressure of approximately 5.6 x 10-3 mbar of argon 99.995% (Praxair, Madrid, Spain). Dwell times of 0.1 s 119 
per SRM transition were chosen. MassLynx v4.1 (Waters) and homemade Excel spreadsheets were used to 120 
process the data obtained. Relative abundances of individual 100 ng/mL standards were determined (n=5) 121 
under this conditions with RSD values under 1.5%. 122 
 123 
Sampling and sample preparation 124 
The aim of the study was explained to 15 healthy volunteers (8 men and 7 women with ages comprised 125 
between 16 and 59 years) and consent was obtained after confirmation that they fully understood the 126 
experiment. Urine samples were collected and stored at -20ºC until use. Testosterone concentration was 127 
approximately determined by IPD for all samples. 12 samples were selected and mixed in pairs in 128 
approximate 1:1 (v/v) ratios to obtain 6 synthetic urine samples, A to F, with increasing concentrations 129 
along the 2 ng/mL to 75 ng/mL testosterone range. 130 
2.5 mL of the synthetic samples were transferred to individual glass tubes, together with 25 µL of 1 µg/mL 131 
13C2-T, and they were neutralized with 1 mL of 1 M phosphate buffer (pH 7.0). Then, 30 µL of β-132 
glucuronidase solution were added. Samples were incubated at 55 ± 2 ºC in a water bath for 1 h. 133 
After hydrolysis, approximately 200 mg of a NaHCO3/Na2CO3 (1:2, w/w) solid buffer were added and 134 
dissolved by stirring in a vortex. Liquid-liquid extraction was performed with 6 mL of MTBE and stirring in a 135 
vortex for 1 min. Separation of phases was achieved by centrifugation at 3500 rpm for 5 min and the upper 136 
organic phase was transferred to clean glass tubes with disposable Pasteur pipettes, carefully avoiding to 137 
transfer any aqueous phase. MTBE was evaporated in a MiVac at 40ºC for 20 min. The residue was 138 
reconstituted in 300 µL of MeOH/H2O 1:1 (v/v) and transferred to LC vials. 139 
Samples and standards were equally treated and analyzed as described above. 140 
 141 
 142 
Quantification methods 143 
The 6 synthetic urine samples (A to F) were analyzed by three quantification approaches: Cal-IS, wCal-IS and 144 
IPD. 145 
Additionally, at IUPA laboratory, standard addition was also employed for the inter-laboratory experiment. 146 
On this purpose, 2.5mL aliquots of each sample were spiked with 0, 0.5, 2 and 3.5 times the original 147 
approximate concentration of T and adjusted to a final volume of 2720 µL with water. The described 148 
sample treatment was applied without the addition of internal standard. 149 
For all participant laboratories, calibration curves freshly prepared consisted in 6 points between 0 and 100 150 
ng/mL of T in 2.5mL of water. Using the same data acquired for calibration with IS, weighed calibration 151 
calculations were applied as described in Garcia-Alonso and Rodríguez-González[19]. The weighing factor 152 
used has been the common value inverse of the variance (1/SD2). 153 
IPD was applied to the same sample extracts used in Cal-IS. 154 
The isotope dilution quantification methodology employed is based on multiple linear regression and the 155 
spiking of samples with an isotopically enriched analog of the analytes of interest. This produces an 156 
intentional alteration of the natural isotopic composition of the analyte in the mix. Briefly, the altered 157 
isotopic composition measured in the mixture   is a combination of the contribution of the 158 
abundances of the natural, 
  , and the isotopically enriched spike,   analyte. For a single 159 
isotopically enriched spike and n measured transitions, this can be expressed in matrix notation as: 160 
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A vector error  needs to be included in order to solve the system by multiple linear regression, which 162 
gives the molar fractions of natural and labelled compounds (Χ
 and Χ respectively) as solutions. 163 
These can be obtained in any spreadsheet software with a linear regression function (LINEST in Microsoft 164 
Excel) inserting the data in matrix form. Then, since the added amount of labelled compound  is 165 
known, the amount of natural compound in the sample 
 is readily calculated (Table S.4. Supplementary 166 
information): 167 
 
 =  Χ

Χ  168 
As it can be seen, no methodological calibration procedures are required and a single injection provides 169 
one concentration value of the sample. The mass isotopomer distribution from each precursor ion has to 170 
be determined experimentally in the mix and compared with the individual distributions corresponding to 171 
the natural and the labeled analyte, the reference distributions. These individual distributions can be 172 
theoretically calculated or experimentally measured. In the present work, they have been experimentally 173 
measured. In a first step, theoretical isotopomer distributions have been obtained by IsoPatrn software 174 
implemented by L. Ramaley and L. Cubero-Herrera[20]. Afterwards, only those transitions producing 175 
instrumental signal significantly different from background have been selected. A thorough description of 176 
the general IPD methodology and its application to different analyte types can be found in the 177 
literature[21-23]. 178 
 179 
Inter-laboratory experiment 180 
For the inter-laboratory variability evaluation of both calibration and IPD methods, four laboratories were 181 
contacted and agreed to collaborate: Barcelona Antidoping Laboratory (Fundació IMIM, Barcelona, Spain), 182 
Doping Control Laboratory (DoCoLab, Ghent University, Ghent, Belgium), Norwegian Doping Control 183 
Laboratory (Oslo University Hospital, Oslo, Norway) and the Department of Physical and Analytical 184 
Chemistry at University of Oviedo (Oviedo, Spain). 185 
Three plastic bags containing 12 mL of frozen samples A to F in individual Falcon tubes, a vial with 1 mL of 186 
13C2-T 10 µg/mL in MeOH and Instructions and Results documents were prepared. The bags were put into 187 
sealed packages with the required amount of dry ice to ensure sub-zero temperature conditions until 188 
arrival to the selected laboratories. Samples were processed and all the required measurements were 189 
performed in order to apply calibration and IPD calculations at our laboratory. In addition, laboratories 190 
were also asked to perform any other routine quantification method they had implemented (Table 2). 191 
Taking into account those extra quantification methods, we got 19 analytical results for each sample. These 192 
results were used to calculate a consensus value for the concentration of each sample, Cref, and its 193 
associated uncertainty, uref. 194 
Table 2. Additional quantification procedures conducted in inter-comparison participating laboratories 195 
Laboratory Additional analytical methods 
IUPA Standard additions (LC-MS/MS) 
DoCoLab GC-MS/MS, LC-HRMS 
Norwegian Doping Control Laboratory GC-MS/MS 
 196 
Uncertainty assessment 197 
In the present work, measurement of uncertainty was evaluated according to WADA technical document 198 
TD2014DL [24] and references therein. Specifically the procedure based in the Nordtest guide [25]. To this 199 
end, an intra-laboratory reproducibility experiment (five replicates of each sample along five weeks) and a 200 
short inter-laboratory comparison have been conducted. Combined uncertainty, ucomb, for each selected 201 
quantification method and sample were calculated and compared. Moreover, the inter-laboratory 202 
reproducibility standard deviation was calculated and compared for the three selected methods. Combined 203 
uncertainty has been calculated as: 204 
!"# = $!% + !&  205 
where u2SD is the intra-laboratory reproducibility standard deviation for the five replicates obtained along 206 
five consecutive weeks at IUPA laboratory and ubias is the uncertainty associated to any source of bias which 207 
accounts for the method and laboratory bias, including the uncertainty associated to the consensus 208 
reference value. To that purpose, a short inter-laboratory comparison was conducted and a whole of 19 209 
quantification results have been obtained for each sample A to F (see inter-laboratory experiment section). 210 
Thus, ubias was calculated as 211 
!& = $'() + !*+,  212 
where uref is the bias uncertainty associated to the consensus concentration value for each sample, Cref, 213 
obtained by: 214 
!*+, = )√. 215 
where SR is the mean standard deviation for the inter-laboratory reproducibility and n is the number of 216 
results for each sample. A n=17 was employed instead of 19 due to exclusion of outliers determined by 217 
Hampel test (see results, Table 3 and Table S.7 from Supplementary Information). 218 
RMS is the root mean square bias for each quantification method used in the intra-laboratory 219 
reproducibility assessment conducted alt IUPA lab (for examples of calculations see Table S.5 in 220 
supplementary material). 221 
For each sample (A to F) a mean bias has been calculated from the intra-lab reproducibility study (n = 5). 222 
These mean bias have been used to calculate RMS as: 223 
'() =  /∑ 1234 6  224 
 225 
On the other hand, contribution of any source of uncertainty to a given measurement, known as full 226 
uncertainty budget, can be calculated using the Kragten approach [26]. Briefly, it consists in an 227 
approximation of error propagation theory calculations adapted for its implementation in spreadsheet 228 
programs (such as Microsoft’s Excel). Calculation tables are constructed with all the parameters used to 229 
obtain the final analytical result including their uncertainty or standard deviation. Then, parameter values 230 
are sequentially altered with their SD to obtain the deviation (Δ2) produced to the analytical result in 231 
relation to the unchanged value, which constitutes the magnitude of contribution to total uncertainty of 232 
the analytical procedure. It is readily calculated for each parameter i as: 233 6 = 78 − 8: 234 
Where x is the unchanged value and xi is the new value with one parameter altered. Then, total uncertainty 235 
of the procedure (U(x)) can be obtained using: 236 
;78: = /< 6  237 
Examples of complete uncertainty calculations can be consulted in the Supplementary Information (Table 238 
S.6). 239 
 240 
RESULTS AND DISCUSSION 241 
IPD measurements 242 
As explained above, IPD calculations rely on the relative abundance distribution of natural and labelled 243 
compounds and, therefore, on their accuracy. For this purpose, the most abundant SRM transitions for 244 
each compound were selected with IsoPatrn software. Then, relative abundances were experimentally 245 
determined by preparing individual 100 µg/L standards in MeOH/H2O 1:1 (v/v) and injecting them five 246 
times each (Tables S.1 and S.2 in supplementary information). Mean values for experimental abundances 247 
were used in subsequent quantification procedure and standard deviations were used in the uncertainty 248 
budgets building procedure. 249 
IPD calculation also requires to know the exact amount of labelled compound added to samples. Exact 250 
concentration of the 13C2-T working standard solution was calculated by reverse isotope dilution (RID) 251 
against the natural T solution, resulting in 12.20 ± 0.10 mg/L. (Table S.3 supplementary information). 252 
 253 
Evaluation of uncertainty 254 
Uncertainty has been assessed as intra-laboratory reproducibility standard deviation and through the 255 
reproducibility of an inter-laboratory comparison. 256 
Intra-laboratory has been conducted at IUPA facilities. Five replicates of the synthetic urine samples (A to F) 257 
have been analyzed along five consecutive weeks. Concentration mean values, as well as standard 258 
deviation and RSD(%) are shown in Table 3. 259 
Regarding intra-lab precision, wCal-IS shows RSD below 5% for any concentration level. IPD quantification 260 
performs slightly better while Cal-IS clearly achieves the worst reproducibility at the lower concentrations, 261 
reaching a value of 15.8 % at 2 ppb level. Concerning the inter-laboratory comparison, results are 262 
qualitatively similar. IPD shows the highest precision, with a mean RSD value around 10%, while wCal-IS 263 
doubles that value. On the other hand, Cal-IS shows the worst performance at the lowest levels, where RSD 264 
reaches values higher than 40%. 265 
 266 
Table 3. Intra-laboratory and inter-laboratory precision data for the three quantification methodologies 267 
assayed and for the consensus value. Cal_IS: non-weighted calibration with internal standard; w-Cal_IS: 268 
weighted calibration with internal standard; IPD: isotope pattern deconvolution. 269 
 Mean ± SD (RSD%) ng/mL 
Sample Intra-lab reproducibility (n=5)a Inter-lab reproducibility (n=5)b Consensus  
 Cal_IS w-Cal_IS IPD Cal_IS w-Cal_IS IPD Cref (n=17)c 
A 1.9 ± 0.3 (15.8) 2.04 ± 0.06 (2.9) 2.10 ± 0.04 (1.9) 2.1 ± 0.9 (43) 2.2 ± 0.4 (18) 2.3 ± 0.3 (13) 2.0 ± 0.4 (20) 
B 3.6 ± 0.3 (8.3) 3.78 ± 0.14 (3.7) 3.87 ± 0.06 (1.6) 4.1 ± 1.0 (24) 4.2 ± 0.8 (19) 4.3 ± 0.4 (9.3) 4.0 ± 0.4 (10) 
C 10.1 ± 0.4 (4.0) 10.3 ± 0.5 (4.9) 10.48 ± 0.22 (2.1) 11.2 ± 1.9 (17) 11.6 ± 2.3 (20) 11.6 ± 0.9 (7.8) 11.2 ± 1.2 (11) 
D 17.1 ± 0.9 (5.3) 17.4 ± 0.8 (4.6) 17.7 ± 0.6 (3.4) 19.5 ± 2.3 (12) 20 ± 4 (20) 20.3 ± 2.2 (11) 20 ± 3 (15) 
E 51.7 ± 1.3 (2.5) 52.0 ± 1.1 (2.1) 52.9 ± 0.9 (1.7) 57 ± 8 (14) 60 ± 13 (22) 60 ± 5 (8.3) 57 ± 6 (11) 
F 67.8 ± 1.9 (2.8) 68.0 ± 1.6 (2.4) 69.2 ± 0.9 (1.3) 75 ± 9 (12) 77 ± 16 (21) 78 ± 7 (9.0) 76 ± 10 (13) 
a Results from IUPA laboratory 270 
b One result from each of the five participant laboratories 271 
c Consensus value calculated as the mean value for the results obtained from all quantification methodologies used in 272 
the interlaboratory comparison. Outlier values were excluded following Hampel test (Table S.7). Associated bias 273 
uncertainty of Cref (uref) calculated from the Mean RSD% is 3.1% (see Table S.5) 274 
 275 
 276 
  277 
Figure 1. Mean inter-laboratory RSD values for the three quantification methods assayed. Concentration 278 
ranges from 2 ng/mL (sample A) to 70 ng/mL (sample F). 279 
 280 
Thus, inter-laboratory reproducibility noticeably shows tendencies with concentration (Figure 1). Cal-IS 281 
performs poorly at low concentrations, with RSD > 40% in sample A, which decreases to values near 12% as 282 
concentrations get higher. In comparison, wCal-IS provided constant values of RSD along the concentration 283 
range (20%), improving uncertainty at low concentrations but performing slightly worse in the rest of the 284 
samples. IPD produced significantly lower dispersion of values resulting in the highest inter-laboratory 285 
precision (from 7.8% to 13%) of the three methods even at low concentrations.  286 
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In addition to intra-laboratory reproducibility, combined uncertainty, uc, were calculated in order to 287 
estimate the measurement uncertainty for the three quantification methods. To this end, method and 288 
laboratory bias were estimated, according to the Nordtest guide [25] (see experimental), as the square root 289 
of two components: the percentage of the mean difference (RMSbias) from a reference value (Cref), and 290 
uncertainty of this reference value, uref. The end value for uc accounts for the method and laboratory bias 291 
together with standard deviation of reproducibility at each concentration assayed (A-F samples) (Table 4). 292 
 293 
Table 4. Combined uncertainty for the three quantification methodologies assayed. 294 
Sample 
Combined uncertainty (%) 
Cal_IS w-Cal_IS IPD 
uref   3.1%   
RMSbias 10.4% 8.3% 6.9% 
ubias 10.9% 8.8% 7.6% 
A 17.9% 9.4% 7.8% 
B 13.2% 9.6% 7.8% 
C 11.7% 10.0% 7.9% 
D 12.0% 10.0% 8.4% 
E 11.2% 9.1% 7.8% 
F 11.3% 9.1% 7.7% 
 295 
The consensus values obtained from the inter-laboratory comparison were adopted as reference values 296 
(Table 3). The consensus values are not intended to be used as certified values, but they were accepted as 297 
reference values to calculate bias uncertainty for each quantification methodology and to assess the bias 298 
associated to that reference value. A uref of 3.1% was obtained from the mean RSD value (12.9%) and n=17 299 
from the 19 quantification procedures applied minus outlier values (see experimental section and 300 
Supplementary Information for details). 301 
Since the data required for Cal-IS and wCal-IS is exactly the same, taking into account the difference in 302 
combined uncertainty (11.2%-17.9% versus 9.1-10.0%) it is worth noting the improved quality of analytical 303 
results due only to the data treatment. 304 
Along with wCal-IS, IPD stands out in comparison with more extensively used methods such as Cal-IS. 305 
Furthermore, IPD also provided combined uncertainties below 8.4% in all the concentration range with the 306 
advantage of reduced time analysis, since no calibration curve procedure had to be performed. 307 
Again, results showed that Cal-IS performs poorly at low concentrations, being the worse method for the 308 
whole concentration range studied. In comparison, wCal-IS provided constant values of combined 309 
uncertainty along the concentration range although higher than IPD, which produced the lowest combined 310 
uncertainties of the three methods at any concentration assayed. This is in accordance with the high 311 
metrological quality of analytical results provided by isotope dilution mass spectrometry 312 
determinations[21]. 313 
Finally, full uncertainty budgets were obtained for the three selected quantification methods according to 314 
the Kragten approach (Table S.6 in supplementary material). 315 
In the case of both wCal-IS and Cal-IS methods, the same 6 parameters were considered, including: 316 
intercept and slope of the linear regression, measurement of the area ratio in the sample (between natural 317 
and labelled compound chromatographic peak areas, Rm), volume of sample (Vs), volume of internal 318 
standard (Vt) and concentration of the natural standard (Cn). Calculations of the contribution of each 319 
parameter to total procedure uncertainty were carried out for the five replicates and the average values 320 
were obtained. 321 
As it can be seen in Figure 2, in the case of Cal-IS, uncertainty contribution coming from the intercept of the 322 
regression is predominant at low concentrations (Sample A) while at high concentrations (Sample F) slope 323 
is the highest contributor to final method uncertainty. Thus, uncertainty for a Cal-IS method will hardly 324 
improve experimentally. Probably, an alternative way to correct bias and its associated uncertainty at low 325 
concentrations could be the use of a single external calibration point forced through the origin, an 326 
approach not tested in the present work. In contrast, when using weighted calibration, the major 327 
contributors to uncertainty were the measurement of sample and internal standard volumes. Thus, one 328 
way to easily reduce uncertainty could be consider the mass instead of volumes. 329 
On the other hand, the parameters considered for uncertainty calculations in IPD quantification were the 330 
following: determination of abundances of the natural testosterone (natT-1, natT-2) and 13C2-testosterone 331 
(labT-1, labT-2) transitions, measurement of those transitions in the sample blend (B-1, B-2, B-3, B-4), 332 
volume of sample (Vs) and volume and concentration of 13C2-testosterone standard added (Vt, Ct). 333 
As it might be expected for an isotope-dilution determination[21], one of the most important parameters in 334 
IPD was the volume of labelled compound added to perform the quantification. As said above, this 335 
contribution to uncertainty could be minimized by weighting the amount of solution added. Moreover, the 336 
measurement of relative abundances in the sample blend, especially the most abundant transitions of 337 
natural (B-1: 289 > 97) and labelled compounds (B-3: 291 > 99), contributed significantly to the final 338 
uncertainty with relative magnitudes from 8.6% to 50%.339 
 340 
Sample Non-weighted calibration Weighted calibration IPD 
A 
   
B 
   
C 
   
D 
   
E 
   
F 
   
 341 
Figure 2. Uncertainty budgets for the quantification methods assayed. 342 
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CONCLUSIONS 344 
In this work, three analytical approaches for the determination of testosterone in urine have been 345 
compared from an uncertainty evaluation point of view. 346 
Firstly, method uncertainty derived from the procedure itself has been evaluated at our laboratory by 347 
applying weighted and non-weighted calibration with internal standard and IPD quantifications to 6 348 
synthetic urine samples, composed of mixed human urine samples, in five different weeks. Inter-day 349 
combined uncertainties for each sample and method were obtained by Nordtest calculation method and 350 
showed similar values for weighted calibration and IPD, below or equal to 10% in all cases, while non-351 
weighted calibration yielded uncertainties ranging from 11.2% to 17.9%. 352 
Secondly, an inter-laboratory experiment was carried out in order to set a reference value for the samples 353 
and to further evaluate inter-laboratory RSD of these three methods. Similarly to the intra-laboratory 354 
experiment, non-weighted calibration presented much higher uncertainty at low concentrations (43%) than 355 
at medium and high concentrations (12%-24%), where it showed a better performance than weighted 356 
calibration (18%-21% along all the range). In contrast, the combined uncertainty associated with IPD 357 
method was lower than the other two in all 6 samples, ranging from 7.8% to 13%. 358 
In addition, Kragten method was applied to intra-laboratory data to obtain the uncertainty budgets for the 359 
considered quantification methods. Thus, linear regression parameters –slope and intercept– were found 360 
to be the major contributors to uncertainty in non-weighted calibration, varying along the concentration 361 
range. In contrast, weighted calibration and IPD methods were more stable in terms of relative 362 
contributions to procedure uncertainty. 363 
Hence, it has been demonstrated that weighted calibration might be more precise than classical calibration 364 
with internal standard, providing similar uncertainties and standard deviations than isotope dilution 365 
methodologies in intra-laboratory reproducibility studies. Moreover, the present IPD methodology yielded 366 
lower inter-laboratory variability and thus, higher metrological quality of the analytical results are 367 
expected.  368 
The results presented in this work for testosterone as a model compound, together with the benefits of 369 
reduced time analysis and matrix effect corrections provided by IDMS-based methodologies, highlights IPD 370 
as a rapid, robust and reliable method. Thus, taking into account the lower uncertainty of the present 371 
analytical approach, IPD is shown as a promising alternative to improve longitudinal fluctuations in steroid 372 
profiling.  373 
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